Trending
Prev Story
Next Story

First GLP-1 pills for weight loss go on sale in Australia

Sydney Morning Herald (SMH) •
November 19, 2026 • 10:13 PM
• By Rachel Rasker
6
6 reads 0 reactions

Patients on lower doses of the new Wegovy pill will pay less than $10 a day.

1 / 5
Swipe Photos

Australians can access the first GLP-1 pills for weight loss through private prescription from Friday, likely boosting sales of the popular drugs already used by more than half a million people here.

Glucagon-like peptide-1 receptor agonists, or GLP-1s, were previously only available through a weekly injection, while the new Wegovy and Foundayo pills are taken as daily oral tablets.

Millions of Australians are expected to use GLP-1s in the coming years, with the drugs boasting powerful health effects including significant weight loss, improved blood glucose control and other metabolic health benefits.

However, experts have warned there is a lack of research into the wider effects of the medications, including the risk of malnutrition, which can cause serious health concerns but go unnoticed as symptoms of nutrient deficiency mimic the side effects of GLP-1s, including fatigue, nausea, diarrhoea and constipation.

The medications work by curbing appetite, slowing digestion and promoting feelings of fullness.

The Wegovy pill, manufactured by Novo Nordisk, was approved by the TGA earlier this month .

It’s taken every morning on an empty stomach and stays stable at room temperature, unlike the injectable Wegovy, which requires refrigeration.

The new tablet’s pricing will vary by dose, ranging from about $260 per month for a 1.5mg tablet to $395 a month for 25mg. For patients on the lower doses, this works out at less than $10 a day.

The pill is cheaper than the injectable, which costs between $350 and $500 per month.

The new tablets are available on shelves from Friday, Novo Nordisk confirmed.

Competing manufacturer Lilly won approval for its rival pill Foundayo on Monday, promising availability “in the coming days”.

However, while doctors could prescribe the drug from the day of approval, stocks are yet to arrive in pharmacies.

Foundayo is a small-molecule, non-peptide GLP-1 receptor agonist taken as a daily pill at any time, without food or water restrictions.

It is expected to cost between $250 and $370 per month, depending on the dose and the pharmacy.

Users need to be prescribed the pills by their doctor, which may also require an out-of-pocket cost.

The Australian government is facing growing pressure to add GLP-1s to the Pharmaceutical Benefits Scheme for weight loss.

The high price point of the medicines mean they remain out of reach for many with obesity, which disproportionately affects low and middle-income individuals.

You have reached your maximum number of saved items.

Remove items from your saved list to add more.

You've used all of your gift articles. 3 more will become available on the 1st of every month.

Prev Swipe Story Next

Same Story from Other Publications

Compare how 6 other independent news outlets reported on this story.

6 Publications
The Age
10h ago
First GLP-1 pills for weight loss go on sale in Australia

First GLP-1 pills for weight loss go on sale in Australia

Patients on lower doses of the new Wegovy pill will pay less than $10 a day.

#glp #wegovy #pills
Compare →
BBC News
1w ago
Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness

Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness

The US Food and Drug Administration says Ozempic, Wegovy, and other weight-loss drugs must have labels about the condition, known as NAION.

#glp #wegovy
Compare →
CNBC World
1w ago
FDA warns of vision loss risk linked to popular GLP-1 drugs like Wegovy, Zepbound

FDA warns of vision loss risk linked to popular GLP-1 drugs like Wegovy, Zepbound

The agency has found evidence of a potential increased risk of a rare eye condition linked to the use of GLP-1 drugs used for weight management and diabetes.

#glp #wegovy
Compare →
SBS News Australia
2w ago
A GLP-1 weight loss pill has been approved in Australia. Here's what we know

A GLP-1 weight loss pill has been approved in Australia. Here's what we know

The medication, traditionally used for diabetes, has been approved for weight management and cardiovascular concerns.

#glp #weight
Compare →
ABC News Australia
2w ago
Will swallowing a pill make weight loss easier, cheaper or safer?

Will swallowing a pill make weight loss easier, cheaper or safer?

A new tablet version of Wegovy, a peptide used to help people lose weight, has been approved for the first time in Australia.

#wegovy #weight
Compare →
Ars Technica
6d ago
Millions in US use unapproved GLP-1s—and use them in unapproved ways

Millions in US use unapproved GLP-1s—and use them in unapproved ways

Cost and access barriers are pushing people to modified use and unapproved versions.

Related Stories

World News
Build #2612